Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Munn

Showing results (51-60 of 185) with videos related to

Pageof 19
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1996
Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. A potential mechanism of antigen-specific peripheral lymphocyte deletionD H Munn, J Pressey, A C Beall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responsesAndrew L Mellor, Derin B Keskin, Theodore Johnson, et al.
Journal of Reproductive Immunology|April 6, 2004
Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specificBabak Baban, Phillip Chandler, Doris McCool, et al.
The Journal of Experimental Medicine|June 12, 2013
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4Rikke B Holmgaard, Dmitriy Zamarin, David H Munn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouseVijay Saxena, Jennifer K Ondr, Albert F Magnusen, et al.
Blood|February 2, 2010
Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotypeZhi-Chun Ding, Bruce R Blazar, Andrew L Mellor, et al.
The Journal of Clinical Investigation|June 15, 1997
Aortic endothelial cells regulate proliferation of human monocytes in vitro via a mechanism synergistic with macrophage colony-stimulating factor. Convergence at the cyclin E/p27(Kip1) regulatory checkpointA S Antonov, D H Munn, F D Kolodgie, et al.
The Journal of Experimental Medicine|January 1, 1995
Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon gammaD H Munn, A C Beall, D Song, et al.
Blood|September 2, 2011
Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?Celalettin Ustun, Jeffrey S Miller, David H Munn, et al.
European Journal of Immunology|March 9, 2007
Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cellsAnna K Manlapat, David J Kahler, Phillip R Chandler, et al.
Pageof 19

Showing results (51-60 of 185) with videos related to

Sort By:
Pageof 19
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1996
Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. A potential mechanism of antigen-specific peripheral lymphocyte deletionD H Munn, J Pressey, A C Beall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responsesAndrew L Mellor, Derin B Keskin, Theodore Johnson, et al.
Journal of Reproductive Immunology|April 6, 2004
Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specificBabak Baban, Phillip Chandler, Doris McCool, et al.
The Journal of Experimental Medicine|June 12, 2013
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4Rikke B Holmgaard, Dmitriy Zamarin, David H Munn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouseVijay Saxena, Jennifer K Ondr, Albert F Magnusen, et al.
Blood|February 2, 2010
Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotypeZhi-Chun Ding, Bruce R Blazar, Andrew L Mellor, et al.
The Journal of Clinical Investigation|June 15, 1997
Aortic endothelial cells regulate proliferation of human monocytes in vitro via a mechanism synergistic with macrophage colony-stimulating factor. Convergence at the cyclin E/p27(Kip1) regulatory checkpointA S Antonov, D H Munn, F D Kolodgie, et al.
The Journal of Experimental Medicine|January 1, 1995
Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon gammaD H Munn, A C Beall, D Song, et al.
Blood|September 2, 2011
Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?Celalettin Ustun, Jeffrey S Miller, David H Munn, et al.
European Journal of Immunology|March 9, 2007
Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cellsAnna K Manlapat, David J Kahler, Phillip R Chandler, et al.
Pageof 19